Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Oestrogen and pain

next article
08.08.2007

Oestrogen plays an important role in determining how sensitive a person is to pain, and the oestrogen receptor known as ER-beta is particularly significant in this context.

 

These are the conclusions of a study from Karolinska Institutet, published in the American scientific journal PNAS.


"This may mark the beginning of the production of a new class of analgesic drugs", says Professor Jan-Åke Gustafsson, Department of Biosciences and Nutrition.

Earlier studies have shown that oestrogen affects how we experience pain, but the mechanisms behind this have been unclear. Oestrogen can bind to two different receptors, known as ER-alpha and ER-beta, and the new study describes results obtained concerning the expression of these two receptors in the spinal cord.

The results show that ER-beta plays an important role in the development of the part of the spinal cord that contains nerve fibres that carry information to the brain. These nerves are important in several functions, including determining how sensitive a person is to pain, and response to sensation in general. ER-beta is the dominant oestrogen receptor during the development of the embryo. The researchers also showed that neuronal development occurs later in mice that lack ER-beta, and that ER-beta is important in the spinal cord of the adult animal for the survival of nerve cells and for the transmission of pain and sensation.

"These results are particularly interesting in the light of preliminary results from pre-clinical studies that suggest that substances that stimulate ER-beta can give pain relief", says Jan-Åke Gustafsson.

Publication:
Estrogen receptor beta is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons
Xiaotang Fan, Hyun-Jin Kim, Margaret Warner, Jan-Åke Gustafsson.
PNAS, Online Early Edition, 6-10 August 2007

For more information, please contact: Professor Jan-Åke Gustafsson Telephone: +46 8 5858 3701 Mobile: +46 70 209 0244 E-mail: jan-ake.gustafsson@mednut.ki.se Press Officer Katarina Sternudd Telephone: +46 8 5248 6066 Mobile: +46 70 614 6066 E-mail: katarina.sternudd@ki.se Karolinska Institutet is one of the leading medical universities in Europe. Through research, education and information, Karolinska Institutet contributes to improving human health. Each year, the Nobel Assembly at Karolinska Institutet awards the Nobel Prize in Physiology or Medicine.

Katarina Sternudd | Source: Informationsdienst Wissenschaft
Further information: ki.se

next article

More articles from Health and Medicine:

nachricht Does hormone treatment predispose patients to breast cancer?
21.11.2008 | CNRS (Délégation Paris Michel-Ange)

nachricht Mechanisms of cardiovascular disease and cancer give clues to new therapies
21.11.2008 | European Science Foundation

B2B Search

Product / Service
Company / Organisation

Latest News

Sustainable garden roofs developed as a new construction material

21.11.2008 | Studies and Analyses

Bees declared the winners in Earthwatch’s ‘irreplaceable species’ battle

21.11.2008 | Ecology, The Environment and Conservation

Hairspray is linked to common genital birth defect

21.11.2008 | Studies and Analyses

Event News

The Automobile – The Transition from Energy Guzzler to Power Supplier

20.11.2008 | Event News

Ministers meet to define the role of space in delivering global objectives

18.11.2008 | Event News

156th Annual Acoustical Society of America (ASA) Meeting in Miami

28.10.2008 | Event News